Immunovant, Inc (IMVT) insider trading
Every open-market stock purchase and sale by Immunovant, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Tiago Girao (CFO) and 5 others sold $1.1M in the last 90 days.
- Last insider buy: Roivant Sciences Ltd. (Insider), $350M, 10 months ago.
Last 12 months: insiders bought $350M (1 buy) and sold $16M (39 sales). Last close $33.30 on Sep 25, 2026.
Recent IMVT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 23, 2026 | Christopher Van Tuyl (C-suite exec) | Sold | $103K |
| Aug 28, 2026 | Atul Pande (Director) | Sold | $64.9K |
| Aug 28, 2026 | Atul Pande (Director) | Bought (not open market) | — |
| Aug 20, 2026 | Melanie Gloria (COO) | Sold | $135K |
| Jul 24, 2026 | Atul Pande (Director) | Sold | $59.7K |
| Jul 24, 2026 | Atul Pande (Director) | Bought (not open market) | — |
| Jul 23, 2026 | Tiago Girao (CFO) | Sold | $263K |
| Jul 23, 2026 | Jay S Stout (CTO) | Sold | $111K |
| Jul 8, 2026 | Melanie Gloria (COO) | Sold | $76.3K |
| Jul 8, 2026 | Jay S Stout (CTO) | Sold | $75.3K |
| Jul 8, 2026 | Jay S Stout (CTO) | Sold | $55.3K |
| Jul 8, 2026 | Christopher Van Tuyl (C-suite exec) | Sold | $45.2K |
| Jul 8, 2026 | Melanie Gloria (COO) | Sold | $4.2K |
| Jul 8, 2026 | Jay S Stout (CTO) | Sold | $4.2K |
| Jul 8, 2026 | Jay S Stout (CTO) | Sold | $3.1K |
| Jul 8, 2026 | Christopher Van Tuyl (C-suite exec) | Sold | $2.5K |
| Jul 2, 2026 | Eric Venker (CEO) | Sold | $119K |
| Jul 1, 2026 | Eric Venker (CEO) | Sold (not open market) | $3.3M |
| Jul 1, 2026 | Eric Venker (CEO) | Bought (not open market) | — |
| Jun 26, 2026 | Jay S Stout (CTO) | Sold | $1.3M |
| Jun 26, 2026 | Christopher Van Tuyl (C-suite exec) | Sold | $572K |
| Jun 26, 2026 | Melanie Gloria (COO) | Sold | $563K |
| Jun 26, 2026 | Tiago Girao (CFO) | Sold | $385K |
| Jun 26, 2026 | Jay S Stout (CTO) | Sold | $262K |
| Jun 26, 2026 | Melanie Gloria (COO) | Sold | $116K |
Who's trading IMVT
- Christopher Van Tuyl, C-suite exec: sold $1.4M (10 sales), last Sep 23, 2026
- Atul Pande, Director: sold $425K (5 sales), last Aug 28, 2026
- Melanie Gloria, COO: sold $1.6M (14 sales), last Aug 20, 2026
- Tiago Girao, CFO: sold $1.4M (3 sales), last Jul 23, 2026
- Jay S Stout, CTO: sold $2.3M (15 sales), last Jul 23, 2026
- Eric Venker, CEO: sold $462K (3 sales), last Jul 2, 2026
- Andrew J. Fromkin, Director: sold $8M (4 sales), last May 28, 2026
- Robert Graham Susman, Director: sold $68K (1 sale), last May 1, 2026
- Jake Bauer, Director: other filings, last Apr 7, 2026
- Douglas J. Hughes, Director: sold $349K (2 sales), last Apr 7, 2026
- Frank Torti, Director: other filings, last Apr 7, 2026
- Roivant Sciences Ltd., Insider: bought $350M (1 buy), last Dec 12, 2025
- Michael Geffner, C-suite exec: sold $70.1K (2 sales), last Oct 22, 2025
Get free alerts when an insider at Immunovant, Inc files a new trade →